Operating income before deduction of amortization: ainos.com (AIMD)
Ainos, Inc. (AIMD) attracts diagnostic experts with innovations in rapid tests, yet a lack of pricing power at the start of sales makes revenue dependent on distributors. EBITDA cash flow reflects liquidity dynamics, with the value stabilizing at 0.00. The situation is further complicated by production in Taiwan, exposing the business to serious geopolitical risks and threats of a trade blockade.
Ainos (AIMD) - metric breakdowns and financial figures
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
- company profitability and valuation multiples indicators:
AIMD - Net Income|Expected Net Income Ainos, Inc.|AIMD - P/E Multiple|Market Cap to Projected Earnings ainos.com|AIMD - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Ainos|AIMD - Operating profit EBITDA|Net earnings per share for the last 12 months Ainos|AIMD - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months ainos.com|AIMD - Earnings growth in current year|Earnings growth forecast for next year Ainos, Inc.
Analysis of all company metrics:Ainos Corporation - AIMD
An investment audit of the issuer requires an analysis of the actual cash flow from operating activities before interest and taxes to eliminate reporting lags. This calculation determines the ability of Ainos, Inc. (AIMD) to monetize patents for microfluidic chips and AI diagnostics, while the operating profit trend reflects the effectiveness of the company's technological advantage in monetary terms.
Competitors of Ainos, Inc. (AIMD)
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|Operating profit EBITDA quidel.com (QDEL)|Operating profit EBITDA OPK (OPKO Health)|Operating income before deduction of amortization CareDx Corp (CDNA)|MRVI - Profit before payment of interest, taxes and amortization|FLGT (Fulgent) - Operating profit before amortization|Standard BioTools Inc. (LAB) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization cytekbio.com (CTKB)|Profit before payment of interest, taxes and amortization OraSure|Exagen Diagnostics (XGN) - Operating income before deduction of amortization|Operating profit before deduction of amortization MDXH (MDxHealth Inc.)|LUCD (Lucid Diagnostics, Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA PRE (Prenetics)|Operating income before deduction of amortization Insight Molecular Diagnostics, Inc. (IMDX)|TRIB - Profit before payment of interest, taxes and amortization|PRPH (ProPhase Labs Inc) - Operating profit before amortization|CODX: Operating profit EBITDA|Operating profit before deduction of amortization Heart Test Labs|Operating profit before deduction of amortization BMRA|Cardio Diagnostics Holdings, Inc. (CDIO) - Operating income before deduction of amortization|Operating profit EBITDA ONCO|Operating profit EBITDA Virax Biolabs Group Limited (VRAX)|Operating profit EBITDA BJDX (Bluejay)|Operating income before deduction of amortization Aspira Women's Health Inc (AWH)|AXDX - Profit before payment of interest, taxes and amortization|Centogene (CNTG) - Operating profit before deduction of amortization|ENZ: Operating profit EBITDA|Operating profit before amortization FRES|Profit before payment of interest, taxes and amortization Genetic Technologies Ltd|Operating profit before deduction of amortization 23andMe Inc (ME)|Operating profit EBITDA PMD
